VRCA

Verrica Pharmaceuticals Inc.

7.10 USD
-0.01 (-0.14%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Verrica Pharmaceuticals Inc. stock is down -15.68% since 30 days ago. The next earnings date is Aug 6, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 6 June’s closed higher than May.

About Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc. develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; VP-103 for treating plantar warts.